Special Considerations in the Management of HIV-Infected Adolescents

  • Author: Lisa Hightow-Weidman, MD, MPH (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 7/5/18 (What's New)

Summary

  • Perinatally and behaviorally infected adolescents face barriers to adherence, such as structural barriers, self-efficacy (one’s sense of their ability to adhere to medications prescribed), and outcome expectancy (one’s sense of benefit from therapy)[Rudy 2008; Rudy 2010]
  • YLHA receiving ART should be routinely screened for adherence levels and offered support services when needed
  • Multimodality interventions are required to address the need for ongoing adherence to ART in adolescents

Action required